All Pharma News
Update to Financial Guidance and 2023 Trading and Notice of Results

Update to Financial Guidance and 2023 Trading and Notice of Results
GLOBENEWSWIRE
05 Mar 2024
Share Share
Oxford Biomedica completes acquisition of ABL Europe

Oxford Biomedica completes acquisition of ABL Europe
GLOBENEWSWIRE
29 Jan 2024
Share Share
Oxford Biomedica is hosting a free webinar to share clients success stories

Oxford Biomedica is hosting a free webinar to share clients success stories
GLOBENEWSWIRE
23 Jan 2024
Share Share
Business Update

Business Update
GLOBENEWSWIRE
07 Dec 2023
Share Share
Oxford Biomedica pays €15M to acquire French CDMO ABL Europe

Oxford Biomedica pays €15M to acquire French CDMO ABL Europe
Joseph Keenan FIERCE PHARMA
05 Dec 2023
Share Share
Oxford Biomedica signs agreement to acquire ABL Europe from Institut Mérieux

Oxford Biomedica signs agreement to acquire ABL Europe from Institut Mérieux
GLOBENEWSWIRE
04 Dec 2023
Share Share
Kyverna Therapeutics & Oxford Biomedica Sign Agreement for LentiVector® Platform

Kyverna Therapeutics & Oxford Biomedica Sign Agreement for LentiVector® Platform
PR NEWSWIRE
20 Sep 2023
Share Share
Oxford Biomedica Plc - INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023

Oxford Biomedica Plc - INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023
GLOBENEWSWIRE
20 Sep 2023
Share Share
Oxford Biomedica pivots by laying off 200 people

Oxford Biomedica pivots by laying off 200 people
Anna Brown ENDPTS
20 Sep 2023
Share Share
Oxford Biomedica to host webinar showcasing the TetraVecta„¢ system

Oxford Biomedica to host webinar showcasing the TetraVecta„¢ system
GLOBENEWSWIRE
07 Sep 2023
Share Share